LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.

Photo by nci from unsplash

TPS9077Background: ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial) is a clinical trial platform of the National Cancer Institute that offers biomarker analysi... Click to show full abstract

TPS9077Background: ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial) is a clinical trial platform of the National Cancer Institute that offers biomarker analysi...

Keywords: alchemist; alchemist adjuvant; targeted therapy; adjuvant targeted; immunotherapy high; therapy immunotherapy

Journal Title: Journal of Clinical Oncology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.